Ligand · RO8
RO8 · N-{[(2Z)-5-bromo-1,3-thiazol-2(3H)-ylidene]carbamoyl}-3-chlorobenzenesulfonamide
RO8, N-{[(2Z)-5-bromo-1,3-thiazol-2(3H)-ylidene]carbamoyl}-3-chlorobenzenesulfonamide (C10 H7 Br Cl N3 O3 S2, 396.7 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- RO8
- Formula
- C10 H7 Br Cl N3 O3 S2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
RO8 in 2 structures; the first of them:
- 2Y5L · orally active aminopyridines as inhibitors of tetrameric fructose 1,6- bisphosphatase · RO8 A1000 · binds VAL17, MET18, GLU20, GLY21, ARG22, ALA24, GLY26, THR27 and 10 more
- 2Y5L · Orally active aminopyridines as inhibitors of tetrameric fructose 1,6-bisphosphatase · RO8 A1000 · binds VAL17, MET18, GLU20, GLY21, ARG22, ALA24, GLY26, THR27 and 10 more
Residues it binds most
GLY 16, THR 16, GLU 16, LEU 16, MET 16, ALA 16, ARG 16, VAL 16, GLN 14, TYR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.